Exploring the Impact of Device Sourcing on Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients With Diabetes: Retrospective Claims Analysis.

ABSTRACT:

Background

Insurance benefit design influences whether individuals with diabetes who require a continuous glucose monitor (CGM) to provide real-time feedback on their blood glucose levels can obtain the CGM device from either a pharmacy or a durable medical equipment supplier. The impact of the acquisition channel on device adherence and health care costs has not been systematically evaluated.

Objective

This study aims to compare the adherence rates for patients new to CGM therapy and the costs of care for individuals who obtained CGM devices from a pharmacy versus acquisition through a durable medical equipment supplier using retrospective claims analysis.

Methods

Using the Mariner commercial claims database, individuals aged >18 years with documented diabetes and an

SUBMITTER: Allaire JC 

PROVIDER: S-EPMC11301113 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature